NOD2 and inflammatory bowel disease: Therefore, regulating the expression of NOD2 to suppress inflammatory responses and promote autophagy may represent an effective therapeutic approach for inhibiting IBD and combating CRC (Guo et al. 2014, 2016; Lee et al. 2011; Li et al. 2017; Yanai et al. 2016; Zhao et al. 2015).